Table 3 Demographics, comorbidities, and days from symptoms onset to diagnosis of 321 patients with COVID-19 stratified according to nasopharyngeal viral load (VL, log10 copies/mL).
From: SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome
VL ≤ 6.33 (1st tertile) (n = 107) | VL 6.34–8.26 (1st to 2nd tertile) (n = 107) | VL ≥ 8.27 (2nd tertile) (n = 107) | p value | |
|---|---|---|---|---|
Age ≥ 70 years | 27 (25.2) | 40 (37.4) | 51 (47.7) | 0.003 |
Male sex | 57 (53.3) | 64 (59.8) | 48 (44.9) | 0.09 |
Arterial hypertension | 40 (37.4) | 57 (53.3) | 53 (49.5) | 0.05 |
Diabetes mellitus | 22 (20.6) | 14 (13.1) | 21 (19.6) | 0.30 |
Chronic lung diseasea | 12 (11.2) | 11 (10.3) | 15 (14.0) | 0.68 |
Cardiovascular disease | 19 (17.8) | 15 (14.0) | 30 (28.0) | 0.03 |
Chronic kidney disease | 5 (4.7) | 7 (6.5) | 10 (9.3) | 0.40 |
Chronic liver disease | 4 (3.7) | 4 (3.7) | 2 (1.9) | 0.66 |
Cancerb | 9 (8.4) | 8 (7.5) | 8 (7.5) | 0.96 |
Days from symptom onset to diagnosis, median (IQR) | 7 (5–12) | 7 (4–10) | 4 (1–7) | 0.27c |
